Poly Medicure reports Q1FY27 revenue up 30.3% to ₹5,253.76 lacs; PAT at ₹852.74 lacs

Poly Medicure reported strong Q1FY27 topline momentum with revenue up 30.3% YoY, but consolidated PAT declined 8.4% and EPS fell, highlighting margin and consolidation effects despite operational growth. The quarter included incremental corporate actions (ESOP grants/allotments), a small Brazil acquisition, and management's stated focus on capacity expansion and doubling international sales. Market relevance is mainly idiosyncratic, with limited broader cross-asset read-through.